Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Zohar Loshitzer currently holds 72,464 shares of Ocata Therapeutics, Inc. (OCAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Zohar Loshitzer has been a net buyer of OCAT stock. They have purchased $22.0K and sold $0 worth of shares.
Zohar Loshitzer's most recent insider trade was on Jan 2, 2019, when they sold 72,464 shares at $3.45 per share.
Zohar Loshitzer serves as Executive at Ocata Therapeutics, Inc. (OCAT). They have executed 34 insider transactions totaling $22.0K over their tenure at the company.
Zohar Loshitzer holds the position of Executive at Ocata Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Zohar Loshitzer has shown a buying trading pattern, with $22.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Zohar Loshitzer was on Mar 8, 2017, when they sold $275.9K worth of LENS shares. This transaction involved 91,959 shares at $3.00 per share.
Zohar Loshitzer currently owns 72,464 shares of Ocata Therapeutics, Inc. (OCAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Zohar Loshitzer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Zohar Loshitzer has 34 Form 4 filings on record as an insider at Ocata Therapeutics, Inc..
Set alerts for Zohar Loshitzer and 40,000+ other insiders.